Passively immunized hairless mice were inoculated cutaneously with herpes simplex virus. Thirty-nine days later, when the primary cutaneous lesions had completely healed, the mice were treated subcutaneously with prednisone. Within 12 to 30 days after starting prednisone treatment, herpesvirus was recovered by skin swabs from 12 of 71 (17%) of the treated mice. This new model has potential application for understanding and treating recurrent cutaneous herpes infections.
MATERIALS AND METHODS Virus. The HWC strain of HSV was isolated originally from a herpetic lip lesion and was passed three times in rabbit kidney cell cultures. It had a titer of 107 plaque-forming units (PFU) per ml when assayed on primary rabbit kidney cells.
Mice. Four-week-old male hairless mice of the HRS/J strain were obtained from the Jackson Laboratories in Bar Harbor, Me. Herpes immune serum. Two-kilogram rabbits were hyperimmunized by a series of three intramuscular inoculations, each containing 2 x 107 PFU of virus, given at weekly intervals. Twice weekly bleedings were begun 10 days after the final virus inoculation and were continued for a total of 10 bleedings. Serum was collected and pooled. Twofold dilutions of the serum were mixed with an equal volume (0.5 ml) of virus, diluted to contain 500 PFU/ml. The serumvirus mixtures were held ovemight at 4 C, and then 0.4 ml of each mixture was added to duplicate petri plates containing primary rabbit kidney cell cultures. After 2 h of incubation at 37 C, the cells were overlayed with agar, and plaques were counted 4 days later. Half of the virus was neutralized by a 1:256 dilution of serum; i.e., the immune serum had a titer of 256.
Method of infection. Each mouse was injected intraperitoneally with 0.5 ml of undiluted immune serum. Forty-eight hours later, the mice were inoculated with virus: the lumbar area was lightly scratched with a hypodermic needle and the undiluted virus suspension was gently applied to the scratched area with a cotton swab.
Scoring of lesions. Development of cutaneous herpesvirus lesions in nonimmunized mice has been described (3, 9) . A similar but delayed course occurred in passively immunized mice. Lesions were scored on a 0 to 4 scale: 0, no lesion; 0.5, lesion <2 mm in length; 1, lesion 2 to 4 mm; 2, lesion 5 
RESULTS
Infection of passively immunized hairless mice gave skin lesions, followed by healing, on 38% of the mice (Table 1) . Thirty-X-our percent of passively immunized mice succumbed to the primary infection, compared with our average experience of 95% death with .nonimmunized controls.
After complete resolution of lesions, except for a slight residual scar in some cases, mice were caged and marked so that each mouse could be studied individually. The recovered mice then were treated with either hydrocortisone or prednisone in an attempt to induce recurrence of the cutaneous lesions. Skin swabs for virus isolation were collected whenever there was evidence of a lesion.
No virus was obtained from recovered mice that were treated with hydrocortisone (Table 1 ). An additional 19 mice from experiment 1, which were inoculated with virus but showed no primary lesion, were also treated with hydrocortisone, but again no lesions developed. Based on these observations, no additional studies were done with hydrocortisone. More encouraging results were obtained with prednisone; i.e., 12% of mice which had recovered from primary lesions yielded demonstrable herpesvirus after prednisone treatment ( Course of the infection is shown diagrammatically ( Fig. 1) Course of cutaneous infection of mice with recurrent herpes. Each curve depicts the response of one of the 12 mice treated with prednisone which showed recurrent skin infection with herpesvirus. Range of scores indicated during the primary lesion represents highest and lowest scores for individual mice in that cage on the designated day. Each mouse was followed individually after starting prednisone with immune serum permitted lesion development and recovery in a higher percentage of mice than was the case when no antibodies were present. For this reason, and because the presence of circulating antibodies at the time of the initial cutaneous infection more nearly simulates the usual human experience, we adopted this procedure. Preliminary experiments indicated that optimal time for pretreatment, to obtain the highest percentage of lesions followed treatment. Abbreviations and symbols: I.S., Herpesimmune serum administered intraperitoneally on day 0; Virus, herpes simplex virus inoculated cutaneously on day 2; Prednisone, prednisone administered subcutaneously on days 41 to 45; +, skin swab yielded herpes simplex virus on designated day; -, skin swab yielded no demonstrable virus on designated day; D, mouse died on designated day.
by healing, was 48 h before inoculation of virus.
Limited attempts to reactivate healed lesions by means of heat, ultraviolet light, or mechanical trauma were unsuccessful. The conclusion that true reactivation has been achieved with prednisone treatment is supported by the fact that the time between primary inoculation of virus and first recovery of recurrent virus ranged from 7 to 10 weeks (see Fig. 1 ). It is of interest that reactivation of another herpesvirus, infec- tious bovine rhinotracheitis, occurred after treating cattle with a corticosteroid (7, 4) .
In the mouse experiments, little difference due to age was noted either in response to the primary infection or in the rate of recurrent virus recovery when animals ranged from 1 to 3 months old at time of initial infection (see Table 1 ). Nor was there any apparent pattern with respect to age of mice and severity of the recurrent lesion (see Fig. 1 ). Indeed, this lack of consistency in lesion severity makes difficult an accurate estimate of rate of recurrence; it can be seen that some of these lesions were barely detectable even though virus was demonstrated in skin swabs. When a consistent response can be achieved, this model should prove valuable for learning more about the biology and therapy of recurrent cutaneous herpes.
